Nomura Healthcare FundDLHIX
Type
Mutual fund
Peer group
Global equity
Net assets
$665.0M
Expense ratio
0.96%
1-year return
+17.6%
3 years, a year
+11.8%
5 years, a year
+7.3%
Holdings
106
What it aims to do.
Macquarie Healthcare Fund seeks maximum long-term capital growth through capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| JOBY Ucb Sa | 5.90% |
| REGN Regeneron Pharmaceuticals, Inc. | 5.46% |
| PFE Pfizer Inc. | 4.83% |
| GILD Gilead Sciences Inc. | 4.40% |
| ABBV AbbVie Inc. | 4.09% |
| MRK Merck & Co., Inc | 3.89% |
| JOBY AstraZeneca PLC | 3.86% |
| JOBY Chugai Pharmaceutical Co Ltd. | 3.73% |
| LLY Eli Lilly & Co. | 3.60% |
| JOBY Roche Holding AG | 3.30% |
More on DLHIX.
- DLHIX overview
- DLHIX holdings
- DLHIX risk
- DLHIX costs
- DLHIX money in and out
- DLHIX share classes
- Compare DLHIX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.